Futura Medical (LSE:FUM) Additional Paid-In Capital : £71.24 Mil(As of Dec. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Futura Medical Additional Paid-In Capital?

Futura Medical's quarterly additional paid-in capital increased from Dec. 2023 (£71.07 Mil) to Jun. 2024 (£71.09 Mil) and increased from Jun. 2024 (£71.09 Mil) to Dec. 2024 (£71.24 Mil).

Futura Medical's annual additional paid-in capital increased from Dec. 2022 (£66.55 Mil) to Dec. 2023 (£71.07 Mil) and increased from Dec. 2023 (£71.07 Mil) to Dec. 2024 (£71.24 Mil).

Futura Medical Additional Paid-In Capital Historical Data

The historical data trend for Futura Medical's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Futura Medical Additional Paid-In Capital Chart

Futura Medical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

Get a 7-Day Free Trial

52.81

66.38

66.55

71.07

71.24

Futura Medical Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Additional Paid-In Capital	Get a 7-Day Free Trial															66.55	70.93	71.07	71.09	71.24

Futura Medical Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Futura Medical Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Futura Medical's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Futura Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (LSE:FUM) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

FAMDF:USA GYX:Germany

Address

40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG

Website

https://www.futuramedical.com

Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives a majority of its revenue from the United Kingdom and the European Union.

Futura Medical Headlines

No Headlines